Patients diagnosed with low-risk thyroid cancer during COVID-19 pandemic: what did they ask surgeons?
Minerva Endocrinol (Torino)
.
2021 Jun;46(2):233-234.
doi: 10.23736/S2724-6507.21.03441-6.
Authors
Pierpaolo Trimboli
1
2
,
Arnoldo Piccardo
3
,
Alessandra Cossa
4
,
Maurilio Deandrea
5
,
Anda M Naciu
6
,
Gaia Tabacco
6
,
Ugo Catrambone
7
,
Giovanni Canale
8
,
Lorenzo Daniele
9
,
Stefano Valabrega
4
,
Andrea Palermo
6
,
Carlo Bellotti
4
Affiliations
1
Clinic for Endocrinology and Diabetology, Lugano Regional Hospital, Lugano, Switzerland - pierpaolo.trimboli@eoc.ch.
2
Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland - pierpaolo.trimboli@eoc.ch.
3
Department of Nuclear Medicine, E.O. Ospedali Galliera, Genoa, Italy.
4
Department of Medical and Surgical Sciences, S. Andrea Hospital, Sapienza University, Rome, Italy.
5
Department of Endocrinology, Diabetes and Metabolism, Center for Thyroid Diseases, Mauriziano Hospital, Turin, Italy.
6
Unit of Metabolic Disease, Campus Bio-Medico University, Rome, Italy.
7
Department of Surgery, E.O. Ospedali Galliera, Genoa, Italy.
8
Division of Otolaryngology, Mauriziano Hospital, Turin, Italy.
9
Unit of Pathology, Mauriziano Hospital, Turin, Italy.
PMID:
34082506
DOI:
10.23736/S2724-6507.21.03441-6
No abstract available
Publication types
Multicenter Study
MeSH terms
COVID-19*
Female
Humans
Italy
Male
Middle Aged
Pandemics*
Patients*
Surgeons*
Surveys and Questionnaires
Thyroid Neoplasms / diagnosis*
Thyroid Neoplasms / surgery